South Korea Medical Cannabis Market, by Application

Growth Outlook

• The South Korea Medical Cannabis Market, by Application market is on a steady long-term growth path. Segment value stands at roughly USD 12 Mn in 2026 and is projected to reach USD 15 Mn by 2027 — a gain of about 27% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Pain Management leads, holding roughly 46% of segment value — the single largest regional share. Neurological Health Management is the second-largest contributor. Mental Health Management make up the remainder, in descending order.
• By 2027, Pain Management alone is expected to reach USD 7 Mn, with Neurological Health Management at USD 5 Mn.

Market Dynamics

South Korea's medical cannabis market has been rapidly growing in recent years, driven by the increasing demand for alternative treatment options and the government's push for legalization. While the market is still in its early stages, it has the potential to become a major player in the global medical cannabis industry.

One of the main driving factors of demand for medical cannabis in South Korea is its potential to treat a wide range of medical conditions. From chronic pain and seizures to anxiety and depression, medical cannabis has been shown to provide relief for a variety of ailments. As traditional pharmaceutical options may come with numerous side effects and addictive properties, many individuals are turning to medical cannabis as a natural and safer alternative.

The most prominent application for medical cannabis in South Korea is pain management. According to a study by the Ministry of Food and Drug Safety, over 20% of South Koreans suffer from chronic pain, and traditional pain relievers may not be effective for everyone. Medical cannabis has emerged as a promising option for those who do not respond well to traditional painkillers, offering a potential effective and natural solution.

Another significant application for medical cannabis in South Korea is in the treatment of epilepsy and other seizure disorders. In 2018, the country's first-ever approved medical cannabis product, Epidiolex, was prescribed to a young patient with Dravet syndrome, a rare form of epilepsy. The success of this treatment sparked hope for many other patients suffering from similar conditions, leading to increased demand for medical cannabis.

Furthermore, there has been a growing interest in medical cannabis as a treatment for mental health disorders, such as anxiety, depression, and PTSD. With mental health issues on the rise in South Korea, especially among young adults and adolescents, medical cannabis has become a promising option for those seeking relief from these conditions. However, due to the stigma surrounding mental health and medical cannabis, there is still a lack of acceptance and understanding from the general public and the medical community.

In conclusion, the demand for medical cannabis in South Korea is driven by its potential to treat a variety of medical conditions, ranging from chronic pain to mental health disorders. As the government continues to push for legalization and more research is conducted on the benefits of medical cannabis, the market is expected to grow even further in the coming years.